Elizabeth K. Seng, PhD

Recent high-quality clinical trial evidence has demonstrated that medications commonly prescribed for migraine prevention in pediatric patients were not superior to placebo for reducing headache symptoms.

Future research should focus on whether cogniphobia can be a modifiable factor in the treatment of patients with migraine.